Who Owns Arbutus Biopharma Stock?
NASDAQ: ABUSHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 66.92%
- Held by insiders
- 15.92%
- Institutional holders
- 232
- Institutions 66.9%
- Insiders 15.9%
- Public and other 17.2%
Who owns Arbutus Biopharma stock?
Institutional investors own about 66.9% of Arbutus Biopharma's shares, spread across 232 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 15.92% of ABUS.
The largest institutional holders are Morgan Stanley (8.93%), Whitefort Capital Management, LP (7.97%) and Blackrock Inc. (6.95%). Together, the top 10 institutions control 45.2% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their ABUS positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ABUS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Morgan Stanley | 17.70M | 8.93% | -31.6% |
| Whitefort Capital Management, LP | 15.79M | 7.97% | +5.8% |
| Blackrock Inc. | 13.77M | 6.95% | +6.2% |
| Two Seas Capital Lp | 8.14M | 4.11% | -57.4% |
| State Street Corporation | 7.87M | 3.97% | +24.1% |
| Rubric Capital Management LP | 7.53M | 3.80% | +13.7% |
| Vanguard Capital Management LLC | 7.01M | 3.54% | +4.8% |
| Barclays Plc | 4.21M | 2.12% | -2.5% |
| Geode Capital Management, LLC | 4.12M | 2.08% | +9.2% |
| Goldman Sachs Group Inc | 3.51M | 1.77% | +218.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ABUS
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 5.03M | 2.54% |
| iShares Trust-iShares Russell 2000 ETF | 4.05M | 2.04% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.88M | 1.96% |
| Morgan Stanley Insight Fund | 2.73M | 1.38% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.80M | 0.91% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.76M | 0.89% |
| MORGAN STANLEY INSTITUTIONAL FUND INC-Inception Portfolio | 1.63M | 0.82% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.52M | 0.77% |
| EQ Advisors Trust-EQ/Morgan Stanley Small Cap Growth Portfolio | 1.30M | 0.66% |
| iShares Trust-iShares Biotechnology ETF | 1.17M | 0.59% |
Frequently asked questions
Who is the largest shareholder of Arbutus Biopharma?
Morgan Stanley is the largest institutional shareholder of ABUS, owning 8.93% of shares outstanding (17.70M shares) as of its latest 13F filing.
What percentage of Arbutus Biopharma is owned by institutions?
Institutions own about 66.9% of ABUS shares and 79.6% of the public float.
How much of Arbutus Biopharma do insiders own?
Insiders, such as officers and directors, own about 15.92% of ABUS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.